Lv1
54 积分 2026-05-20 加入
New insights into postrenal transplant hemolytic uremic syndrome
10小时前
待确认
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial
7天前
已完结
TMA secondary to SLE: rituximab improves overall but not renal survival
28天前
已完结
Eculizumab Improves Renal Survival in Complement-Mediated TMA Secondary to SLE
28天前
已完结
Evaluation of the post-marketing safety of eculizumab from 2007 to 2025: A real-world pharmacovigilance study and signal analysis based on the FAERS database
1个月前
已完结
[Consensus on diagnosis and treatment of complement-mediated kidney diseases]
1个月前
已完结
A systematic review of short-term outcomes in patients with anti–factor H associated atypical HUS managed with plasma exchanges versus eculizumab
1个月前
已完结
Eculizumab Improves Renal Survival in Complement-Mediated TMA Secondary to SLE
1个月前
已完结
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs
1个月前
已完结
Real-world safety profile of eculizumab: an analysis of FDA adverse event reporting system and systematic review of case reports
2个月前
已完结
皖公网安备34019202002308
